Abstract:BACKGROUND:Cell therapy is proposed to be a potential treatment for Parkinson's disease (PD). Although fetal retinal pigment epithelial (RPE) cells have been tested in trials for treating PD patients, controversy has been raised over the issue of whether such cells can be reprogrammed into dopamine-producing cells for therapeutic efficacy. Here, we aim to investigate whether adult human RPE cells can be reprogrammed into dopamine-producing cells both in vitro and in the recipient monkey brain.METHODS:The RPE layer was isolated from frozen posterior eyeball tissue after penetrating keratoplasty surgery. The tumorigenicity of RPE cells was examined by G-banding and a tumor formation assay in nude mice. Immunogenicity was measured using a one-way mixed lymphocyte reaction (MLR) assay. Dopamine-production in chemically reprogrammed RPE cells was measured by HPLC. Finally, RPE cells were grafted into the brains of monkeys with MPTP-induced PD in order to investigate the potential of such cells treating PD patients in the future.RESULTS:RPE cell lines have been successively established from adult human eye tissues. Such cells can be chemically reprogrammed into dopamine-producing cells in vitro. Moreover, after being grafted into the brain caudate putamen of monkeys with MPTP-induced PD, RPE cells became tyrosine hydroxylase-positive cells, and recipient PD monkeys showed significant improvement of clinical conditions.CONCLUSIONS:This preclinical study using a primate model indicates that human adult RPE cells could be a potential cell source for the treatment of PD in the future.

Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Differentiation and Characterization of Rhesus Monkey Atrial and Ventricular Cardiomyocytes from Induced Pluripotent Stem Cells.

Application Potential of Induced Pluripotent Stem Cells in Cell Therapy for Stroke

The Long-Term Survival and Functional Maturation of Human Inpc-Derived Neurons in the Basal Forebrain of Cynomolgus Monkeys

Intracerebral Transplantation of Differentiated Human Embryonic Stem Cells to Hemiparkinsonian Monkeys.

Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model.

Differentiation of Adult Human Retinal Pigment Epithelial Cells into Dopaminergic-Like Cells in Vitro and in the Recipient Monkey Brain

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Induced neural stem cells from Macaca fascicularis show potential of dopaminergic neuron specification and efficacy in a mouse Parkinson's disease model

Tracking Induced Pluripotent Stem Cells-Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys.

Generation of Naive Induced Pluripotent Stem Cells from Rhesus Monkey Fibroblasts.

Transplanted Autologous Neural Stem Cells Show Promise in Restoring Motor Function in Monkey Spinal Cord Injury

MHC matching improves engraftment of iPSC-derived neurons in non-human primates

Therapeutic function of iPSCs-derived primitive neuroepithelial cells in a rat model of Parkinson's disease

Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model

Therapeutic function of a novel rat induced pluripotent stem cell line in a 6‑OHDA‑induced rat model of Parkinson's disease

Neural Stem Cells Transplanted into Rhesus Monkey Cortical Traumatic Brain Injury Can Survive and Differentiate into Neurons

Rhesus Monkey Neural Stem Cell Transplantation Promotes Neural Regeneration in Rats with Hippocampal Lesions.

Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice

Human induced pluripotent stem cell/embryonic stem cell-derived pyramidal neuronal precursors show safety and efficacy in a rat spinal cord injury model